Cargando…

Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection

AIM: In this study, we conducted a comparative study to explore the differences in therapeutic efficacy and intestinal microbiome of fecal microbiota transplant (FMT) vs. FMT in addition with Lactobacillus (FMT-L) for treatment of recurrent Clostridioides difficile infection (R-CDI). METHODS: We des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garza-González, Elvira, Mendoza-Olazarán, Soraya, Morfin-Otero, Rayo, Ramírez-Fontes, Andrea, Rodríguez-Zulueta, Patricia, Flores-Treviño, Samantha, Bocanegra-Ibarias, Paola, Maldonado-Garza, Héctor, Camacho-Ortiz, Adrián
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6955117/ https://www.ncbi.nlm.nih.gov/pubmed/31976311 http://dx.doi.org/10.1155/2019/4549298

Ejemplares similares

An Update on Clostridioides difficile Binary Toxin
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2022)

Screening of biomarkers of drug resistance or virulence in ESCAPE pathogens by MALDI-TOF mass spectrometry
por: Flores-Treviño, Samantha, et al.
Publicado: (2019)

rUTI Resolution After FMT for Clostridioides difficile Infection: A Case Report
por: Aira, Andrea, et al.
Publicado: (2020)

Effectiveness of FMT in recurrent Clostridium difficile infection
por: Grzesiowski, P, et al.
Publicado: (2015)

Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides difficile Infection. Is There a Role of FMT in Primary Severe CDI?
por: Popa, Daniel, et al.
Publicado: (2021)

Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)

Draft genome sequences of two opportunistic pathogenic strains of Staphylococcus cohnii isolated from human patients
por: Mendoza-Olazarán, Soraya, et al.
Publicado: (2017)

Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection
por: Youngster, Ilan, et al.
Publicado: (2016)

Step-up fecal microbiota transplantation (FMT) strategy
por: Cui, Bota, et al.
Publicado: (2016)

Monkeypox and fecal microbiota for transplantation(FMT): An unprecedented risk?
por: Owais, Rabia, et al.
Publicado: (2022)

1211. Response to Fecal Microbiota Transplant (FMT) in Refractory Clostridioides difficile Infection (CDI) is Modest Compared to Recurrent CDI in Hospitalized Patients
por: Shin, Jae Hyun, et al.
Publicado: (2020)

High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2019)

2407. Overexpression of Virulence Factors in Biofilm from Recurrent Clostridium (Clostridioides) difficile Infection Isolates.
por: Tijerina, Laura, et al.
Publicado: (2019)

Transcriptomic analysis of biofilm formation in strains of Clostridioides difficile associated with recurrent and non-recurrent infection reveals potential candidate markers for recurrence
por: Rubio-Mendoza, Daira, et al.
Publicado: (2023)

How to Apply FMT More Effectively, Conveniently and Flexible – A Comparison of FMT Methods
por: Varga, Adorján, et al.
Publicado: (2021)

Current knowledge on the laboratory diagnosis of Clostridium difficile infection
por: Martínez-Meléndez, Adrián, et al.
Publicado: (2017)

Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children
por: Fareed, Shaaz, et al.
Publicado: (2018)

1122. Evaluation of Fecal Microbiota Transplant (FMT) in Elderly Patients With recurrent Clostridium difficile Infection (CDI)
por: Hassoun, Ali, et al.
Publicado: (2018)

Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection
por: Chehri, Mahtab, et al.
Publicado: (2018)

1929. Evaluating Disparities in Recurrent Clostridioides difficile Infection (CDI) and Fecal Microbiota Transplant (FMT) Treatment using Geospatial and Social Vulnerability Analytic Tools
por: Little, Keighly, et al.
Publicado: (2023)

Fecal Microbiota Transplantation (FMT) as an Adjunctive Therapy for Depression—Case Report
por: Doll, Jessica P. K., et al.
Publicado: (2022)

Species identification of Enterococcus spp: Whole genome sequencing compared to three biochemical test‐based systems and two Matrix‐Assisted Laser Desorption/Ionization Time‐of‐Flight Mass Spectrometry (MALDI‐TOF MS) systems
por: Garza‐González, Elvira, et al.
Publicado: (2020)

Clinical characteristics associated with the severity of Clostridium [Clostridioides] difficile infection in a tertiary teaching hospital from Mexico
por: Tijerina-Rodríguez, Laura, et al.
Publicado: (2022)

615. Can We Restore the Lung Microbiome with Fecal Microbiota Transplant (FMT)?
por: Mendez, Roberto, et al.
Publicado: (2018)

Durability and Long-Term Clinical Outcomes of Fecal Microbiota Transplant (FMT) Treatment in Patients with Recurrent C. difficile Infection
por: Mamo, Yafet, et al.
Publicado: (2017)

1789. Frequency of Chikungunya, Dengue, and Zika Virus in Acute Febrile Illness in Paired Urine and Serum Samples in Mexico
por: Perez Alba, Eduardo, et al.
Publicado: (2019)

FDA's pathway for regulation of FMT: not so fraught
por: Riley, Margaret F., et al.
Publicado: (2015)

FMT in IBS: how cautious should we be?
por: El-Salhy, Magdy
Publicado: (2021)

Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation
por: Zhang, Wanying, et al.
Publicado: (2020)

Molecular and microbiological report of a hospital outbreak of NDM-1-carrying Enterobacteriaceae in Mexico
por: Bocanegra-Ibarias, Paola, et al.
Publicado: (2017)

Fecal Microbiota Transplantation (FMT) for Recurrent/Refractory Clostridium difficile Infection (CDI) in Pediatric Immunocompromised Patients: A Single-center Experience
por: Kwendakwema, Natasha, et al.
Publicado: (2017)

Randomized clinical trial to evaluate the effect of fecal microbiota transplant for initial Clostridium difficile infection in intestinal microbiome
por: Camacho-Ortiz, Adrián, et al.
Publicado: (2017)

Hybrid µCT-FMT imaging and image analysis
por: Gremse, Felix, et al.
Publicado: (2015)

Effect of antibiotic pretreatment on bacterial engraftment after Fecal Microbiota Transplant (FMT) in IBS-D
por: Singh, Prashant, et al.
Publicado: (2022)

The successful containment of a hospital outbreak caused by NDM-1-producing Klebsiella pneumoniae ST307 using active surveillance
por: Bocanegra-Ibarias, Paola, et al.
Publicado: (2019)

Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Review of the Impact of Biofilm Formation on Recurrent Clostridioides difficile Infection
por: Rubio-Mendoza, Daira, et al.
Publicado: (2023)

Microbiological and Molecular Characterization of Staphylococcus hominis Isolates from Blood
por: Mendoza-Olazarán, Soraya, et al.
Publicado: (2013)

SARS-CoV-2 vaccines and donor recruitment for FMT
por: Ianiro, Gianluca, et al.
Publicado: (2021)

Increasing rates of Clostridium difficile infection in Mexican hospitals
por: Dávila, Laura Palau, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_a3unfju27fvfepq743nt5rl4ku